News | Radiation Therapy | May 20, 2016

Elekta Surpasses 1 Million Patients Treated with Leksell Gamma Knife

Latest iteration of stereotactic and radiation therapy platform to be installed at five new sites in coming months

May 20, 2016 — At the 18th International Leksell Gamma Knife Society Meeting in Amsterdam, May 15-19, Elekta announced the Leksell Gamma Knife radiosurgery system has been used in the treatment of more than 1 million patients. The system has been used on patients afflicted with brain tumors, vascular malformations and functional disorders.

Today, Gamma Knife surgery is performed on more than 75,000 patients every year in hundreds of hospitals and clinics around the world. The average clinical volume per treatment site has also steadily grown each year due to a proliferation of supporting clinical evidence and product enhancements that improve clinical efficiency.

Leksell Gamma Knife Icon, the newest generation of the system, is currently being used to treat patients in Europe, the United States and Asia. Icon expands on the capabilities of Gamma Knife, while providing additional frameless flexibility for either accurate single-dose administration or fractionated multiple treatment sessions over time, enabling treatment of larger tumor volumes, targets close to critical brain structures and new or recurring brain metastases.

In the coming months, installations of Icon are planned at several leading centers including The University of Texas MD Anderson Cancer Center (Houston), University of Pittsburgh Medical Center (Pittsburgh), University of Virginia Health System (Charlottesville, Va.), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, Netherlands) and Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland).

Metastatic brain tumors and other neurological disorders negatively impact survival and quality of life in a large and growing patient population. Worldwide, more than 256,000 new cases of brain and other central nervous system (CNS) tumors are diagnosed annually, with an estimated 189,000 deaths.

“Gamma Knife radiosurgery is a proven approach that has helped us resolve complex brain lesions, vascular complications and other neurological abnormalities, many of which were previously thought to be inoperable,” said Jean Regis, M.D., neurosurgeon and Gamma Knife program director, University Hospital La Timone, Marseille, France, who has performed more than 16,000 Gamma Knife procedures. “Over the past four decades, we’ve established a wide body of clinical evidence supporting Gamma Knife radiosurgery in the treatment of diverse brain and central nervous system pathologies, and in my experience, this is an attractive option for patients and clinicians, enabling a significant reduction in radiation exposure to healthy tissue and a negligible post-procedural convalescence period where the typical patient can usually leave the hospital within an hour.”

Douglas Kondziolka, M.D., a researcher and neurosurgeon who has performed many thousands of Gamma Knife procedures, added “Gamma Knife radiosurgery is an excellent example of how evolving cancer care technologies are addressing growing demand for precision medicine, where treatments can be precisely tailored to an individual’s unique anatomy and biologic makeup while simultaneously helping to reduce the risk of damaging healthy tissue. As one of the most comprehensively studied tools in the neurosurgery armamentarium, we can confidently offer this treatment option as a minimally invasive alternative to traditional brain surgery or whole brain radiation therapy for properly selected patients.”

“Receiving a brain tumor diagnosis is nothing short of shocking, but I feel incredibly fortunate to have discovered an effective alternative to traditional open surgery,” said Josh Perry, 27-year-old pro BMX athlete who underwent an open craniotomy for a meningioma and then received Gamma Knife to treat a recurrence several years later. “In contrast to my first procedure, which took six hours and required a two month recovery, I was up and talking minutes after receiving Gamma Knife and back on my bike within a week.”

Stereotactic radiosurgery is a non-invasive alternative to traditional brain surgery and radiation therapy for the treatment of complex, difficult to treat brain conditions. Using up to 192 precisely focused sources of radiation, Gamma Knife controls malignant and nonmalignant tumors, as well as arteriovenous malformations, essential tremor and trigeminal neuralgia while limiting damage to healthy tissue. The extremely high precision of Gamma Knife surgery is achieved using a three-dimensional coordinate system to locate and treat small targets inside the head.

For more information: www.gammaknife.com

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...